[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
“This approval marks a new class of antiretroviral medications that may benefit patients who have run out of HIV treatment options,” said Jeff Murray, M.D., deputy director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research. “The availability of new classes of antiretroviral drugs is critical for heavily treatment-experienced patients living with multidrug resistant HIV infection—helping people living with hard-to-treat HIV who are at greater risk for HIV-related complications, to potentially live longer, healthier lives.”
When Rabbi James Gibson arrived at Temple Sinai in 1988 at age 34, the Squirrel Hill congregation had seen a succession of rabbis come and go in short order.
Rabbi James Gibson of Temple Sinai in Pittsburgh
“The betting money was not on me,” Rabbi Gibson recalled. But he soon made clear he was committed to staying and fulfilling basic commitments to teaching, pastoral work and community service.
After 32 years as not only Temple Sinai’s rabbi but also as one of the most prominent participants in building interfaith and inter-racial ties in Pittsburgh’s religious communities, Rabbi Gibson will bring that tenure to a close when he retires following this weekend’s Shabbat services. The congregation had planned big celebrations, including a dinner and concerts, but the pandemic changed all that.
Instead, he’ll be leading the final Friday night service via livestream from Temple Sinai and other activities via Zoom on Saturday. “I cannot imagine ending my career and not being in sacred space,” he said. On Sunday, members will hold an outdoor “drive-bye” farewell, he said.
“It has been a 32-year love affair,” he added. “There have certainly been challenges, but … every time we confronted something difficult and acted on our best values, we have ended up where we were supposed to be.”
Rabbi Gibson, known to friends as Jamie, grew up mostly in northern New Jersey and Minnesota.
After graduating from the University of Michigan, “I spent three years doing every job under the sun,” he recalled.
At 24, he entered Hebrew Union College-Jewish Institute of Religion — the rabbinical school for the liberal Reform Jewish movement. He studied at its programs in Cincinnati and Jerusalem and earned a master’s degree.
He then served a congregation in Wausau, Wis., for five years. “I was the only rabbi in around 100 miles in every direction,” he recalled, even traveling as far as Michigan’s Upper Peninsula to conduct funerals.
A denominational official who had grown up at Temple Sinai put him in contact with current leaders. Knowing it had gone through an unhappy succession of short-term rabbis, he told Rabbi Gibson: “Why don’t you go and make peace in Pittsburgh and be my mother’s rabbi?”
When he first met temple leaders at a conference, “he looked really, really young” but proved to be “mature beyond his years,” recalled Rhoda Dorfzaun, who was president of Temple Sinai at the time.
“He seemed to have the same philosophy that our temple had,” she added, which has included being welcoming to interfaith couples and LGBT people.
Earlier today the Department of Health and Human Services released a final rule that eliminates federal regulations ensuring nondiscrimination in healthcare for transgender people and LGB people, people who are pregnant or seeking an abortion, those who require healthcare services in a language other than English, and other marginalized communities. In its announcement, HHS noted it was “restoring the rule of law” by interpreting sex discrimination “according to the plain meaning of the word ‘sex’ as male or female and as determined by biology.”
GLMA President Scott Nass, MD, MPA, issued the following statement in response:
“It is unconscionable that the Administration would take this action to encourage and promote discrimination during a pandemic that is already severely impacting vulnerable communities, including LGBTQ people. The fear of discrimination can have very real health consequences, especially in a public health crisis. These discriminatory measures are not only cruel, they also undermine public health and will assuredly result in poorer health outcomes for LGBTQ people.
By the end of 1984, AIDS had already ravaged the United States for a few years, affecting at least 7,700 people and killing more than 3,500. Scientists had identified the cause of AIDS—HIV—and the U.S. Centers for Disease Control and Prevention (CDC) identified all of its major transmission routes.
Yet, U.S. leaders had remained largely silent and unresponsive to the health emergency. And it wasn’t until September 1985, four years after the crisis began, that President Ronald Reagan first publicly mentioned AIDS.
But by then, AIDS was already a full-blown epidemic.
HIV originated in 1920 in Kinshasa, Democratic Republic of Congo. It spread to Haiti and the Caribbean before jumping to New York City around 1970 and California within the decade.
Health officials first became aware of AIDS in the summer of 1981. Young and otherwise healthy gay men in Los Angeles and New York began getting sick and dying of unusual illnesses normally associated with people with weakened immune systems.
It didn’t take long for fear of the “gay plague” to spread quickly among the gay community. Beyond the mortal danger from the disease, they also dealt with potentially being “outed” as homosexual if they had AIDS or an illness resembling it.
In fall 1982, the CDC described the disease as AIDS for the first time. Despite the growing cases and a new name, news outlets struggled with the disease, or at least how to cover it—some even shied away from giving it too much attention. Though the New York Times initially reported on the mysterious illnesses in July 1981, it would take almost two years before the prestigious paper gave AIDS front-page space on May 25, 1983. By that time, almost 600 people had died from it.
David W. Dunlap, a reporter in the Metro section at the time, told the New York Times Style Magazine: “There were strong messages that you got that were not written on any whiteboard. You knew to avoid it. It was a self-reinforcing edict: Don’t write about queers.”
In a letter to Robert Torres, Secretary of Aging Pennsylvania Department of Aging, representatives of the PA Commission on LGBT Affairs wrote:
In February, the Aging Workgroup of the Commission on LGBTQ Affairs developed a survey to hear from aging service providers and LGBTQ consumers across the Commonwealth. The survey was completed by over 400 individuals, representing both service providers and older Pennsylvanians. The Workgroup used this survey data to craft the recommendations […] LGBTQ older adult respondents expressed great concern over being able to access LGBTQ-friendly resources and services. A strong majority indicated they would more readily access these services if they knew providers had completed LGBTQ cultural competence training. Providers also identified the need for greater training within the aging network to develop the knowledge and skills needed to more effectively serve LGBTQ older adults and individuals living with HIV. They reported wanting more resources that they could share with co-workers to improve their agencies, and resources to share with clients to help them connect to LGBTQ-friendly services. Providers and consumers both identified the need for non-discrimination protections, improved data collection, and greater support for LGBTQ people in the long-term care system.
A formal document regarding recommendations to the Department of Aging, at the Pennsylvania Department of Health, include:
Expanding LGBTQ cultural competence within all levels of care providers
Develop training opportunities and resources on the topic of HIV & Aging
Support advocacy efforts for LGBTQ older Pennsylvanians
Establish mechanisms for collecting data on sexual orientation and gender identity
Provide training materials for aging services providers
Identify opportunities to partner and support LGBTQ affordable, inclusive housing initiatives
Develop and share resources related to LGBTQ aging with all levels of care providers
Develop programs that deal with social isolation, including training seniors on the use of social media technologies
You can find out more in the official document, with the full list of recommendations, submitted to the Department of Aging here. For more information about the Department of Aging, go here.
AIDS Free Pittsburgh wants to hear YOUR ideas about how we can work together to end the HIV epidemic in Allegheny County, whether or not you know someone affected by HIV. This is an ambitious goal, and we are hard at work developing an updated plan to dramatically reduce HIV in our community.
Your input is important to make sure that this project is successful. This survey will take about 15 minutes to complete, is completely anonymous and voluntary. Your responses will not be shared with others and you may stop at any point.
What is AIDS Free Pittsburgh? It is a community public health project that began in 2015 to decrease new HIV cases by 75% and eliminate new AIDS cases in Allegheny County, Pennsylvania by the year 2020. AIDS Free Pittsburgh partners have committed to a three-pronged strategy with the goal of creating a community where new HIV infections are rare:
TEST: Identify people with HIV who remain undiagnosed and connect them to care.
PREVENT: Increase education about and access to Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) for people who are at higher risk for HIV.
TREAT: Support immediate linkage to care for people diagnosed with HIV to maximize viral suppression so they can remain healthy and prevent further HIV transmission.
As of 2018, new HIV cases have decreased by 39% and new AIDS cases have decreased by 43% in Allegheny County. It is exciting that we are about halfway to meeting these goals, but we still need your help to cross the finish line. We are currently planning a second phase of the project (2021-2025) and are looking for your input!
Questions or concerns?
Contact AIDS Free Pittsburgh by email at email@example.com.
Our long-time Executive Director will retire in 2020 after decades of service to our organization and our mission. The Board of Directors is seeking to hire a new Executive Director who can build upon the strong reputation and impactful services in place and take the organization to new heights of fulfilling our mission.
Visit swconline.orgto learn more about Shepherd Wellness Community.
Review the Executive Director Position Description, including required and preferred credentials, experience, and expertise at com.
Submit a cover letter and resume through the job posting located on indeed.com.
Applications are due no later than 5:00 PM EST on May 29, 2020. This timeline may be extended without notice.
Cover letters and resumes must be submitted through the job posting on Indeed.com.
August “Buzz” Pusateri played an integral role in the Pitt Men’s Study, a confidential research study of the natural history of HIV and AIDS. Not only did he believe in the importance of recruiting volunteers to help further research, he was one of the project’s first volunteers. Twice a year, sometimes more, Pusateri visited the clinic to give blood and answer detailed questions about his life. He also participated in special studies.
“Buzz got it across to the community … that this had to be done for them to defeat this epidemic of AIDS,” said Charles Rinaldo, a scientist and investigator of the Pitt Men’s Study. “He was central to it. He was always there. He was a tough guy, too.”
August “Buzz” Pusateri
Pusateri, a long-term HIV survivor, died on Monday, according to a tribute on the Pitt Men’s Study website. He was 81. Pusateri was a well-known community activist, a founding member of the Pitt Men’s Study community advisory board, and a volunteer with Shepherd Wellness Community. He had been involved in the Pitt Men’s Study since recruitment began in 1984.
“It’s just a horrible loss,” Rinaldo said. “He was our go-to person as far as connecting with the community. He was number one in making sure the community understood.”
Pusateri tested positive for HIV more than 30 years ago. He told the Tribune-Review in 2015 “it’s been an up-and-down battle.”
“Really, with this HIV, you never know what’s going to happen to you,” Pusateri said in 2015.
The Pittsburgh resident was the longest serving chair of the community advisory board, the direct link between the researchers and LGBTQ community, Rinaldo said.
Despite having health problems in more recent years, Pusateri would still come to the board meetings, Rinaldo said.
“I called him the ‘Iron Man’ and he was,” Rinaldo said. “He had health issues, but that didn’t stop him.”
Close friend Richard Vinski said Pusateri was extremely inspirational and motivating.
“Any time something hit him or he ended up in the hospital … he’d say, ‘I’m going to beat this,’” Vinski said. “He just had a great outlook on life and he motivated people because of his strength.”
“If you looked at him he was a frail, small man toward the end of his life, but he was a big guy when it came to getting people moving and giving them the right point of view,” Vinski said.
Pusateri was proud to be a long-term HIV survivor, and shared his experiences publicly to combat stigma and prove that people living with HIV could have full and meaningful lives, officials with Shepherd Wellness Community said.
A pharmacist, Pusateri would often speak to center members about the need for careful adherence to their HIV/AIDS regimens. Shepherd Wellness Community is an AIDS Community center that helps people living with HIV/AIDS.
“Buzz volunteered in our kitchen for five years before joining our staff as chef from 1998-2006,” Shepherd Wellness Community officials said in a statement. “He delighted in planning menus and preparing meals that were high-quality, delicious and nutritious. He always beamed with joy when our community gathered to enjoy his sumptuous dinners.”
Pusateri also hosted movie nights at the center, sharing his love for classic cinema. Vinski said his friend was a collector of old movies.
August “Buzz” Pusateri passed away on Monday, May 4th. Buzz was a well-known community activist who dedicated much of his life to combating AIDS. He was a founding member of the Pitt Men’s Study community advisory board and volunteered for the Shepard Wellness Community. The Pittsburgh Post-Gazette wrote a feature about Buzz back in 2001, which you can find here.
Buzz will be missed but his contributions to the LGBTQ community will continue well into the future. Here are just a few tributes from friends and colleagues:
From Dr. Charles Rinaldo, principle investigator of the Pitt Men’s Study…
I am extremely saddened to inform you that long time founding member and chair of the Pitt Men’s Study Community Advisory Board, LGBTQ advocate and dear friend August “Buzz” Pusateri passed away overnight. We in the Pitt Men’s Study have known Buzz for 35+ years. He was always there for us. This is a terrible loss.
From Dr. Larry Kingsley, co-investigator of the Pitt Men’s Study…
Buzz was the best of the rest of us. I remember him since 1984 when he was gracious enough to pilot test the first MACS questionnaire, which I administered. He never flinched. He gave far more to us than we could return. Buzz is on my mensch list, which is short.
From the Shepherd Wellness Community…
Buzz volunteered in our kitchen for five years before joining our staff as chef from 1998-2006. He delighted in planning menus and preparing meals that were high-quality, delicious and nutritious. He always beamed with joy when our community gathered to enjoy his sumptuous dinners.
A longtime advocate for HIV/AIDS, Buzz was proud to be a long-term survivor. He shared this experience publically to combat stigma and proclaim that people living with HIV can have full and meaningful lives. Buzz also had a career as a pharmacist and would often speak to our members about the need for careful adherence to their HIV/AIDS regimens.
A man of many interests, Buzz loved classic cinema and he delighted in hosting movie nights at our center where he presented the background of each film, accompanied by his review. We remember Buzz for being deeply spiritual and a devoted and active member of St. Paul Cathedral.
From the Delta Foundation…
Buzz’s community contributions are long: He was on the board of the Lambda Foundation, was a founding member of Community Advisory Board at the Pitt Men’s Study, founded Dignity Pittsburgh (and was their the longest serving treasurer and secretary), was a long-time supporter of Shepherd Wellness Community, and was a founder of the Pittsburgh Coffeehouse. He was also a proud member of the Board of Directors for the Delta Foundation and was recently named an Emeritus member. Buzz was out and proud at a time when the LGBTQ community was invisible and was always advocating against the stigma that still remains to this day as a person living with AIDS.
From Persad Center…
Buzz was a man that set the bar for dedication and compassion among LGBTQ advocates in the Pittsburgh area for the last few decades. He is fondly remembered by so many for his loyalty and drive to help those living with HIV. He was an inspirational human being, and often helped folks find their place when it came to helping others in the LGBTQ community. He was a joy to work with and be around and helped so many people. He will be missed.
A memorial will be scheduled at a later date. Details to follow.
A team of scientists from St. Michael’s Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.
Dr. Darrell Tan
The trial will examine whether post-exposure prophylaxis (PEP), which is a medication a person takes once they’ve been exposed to a virus to prevent infection, could halt or slow the spread of COVID-19 in groups of people who have been exposed to a confirmed case. The drug in question – Kaletra (lopinavir/ritonavir as PEP)- has long been used in this capacity to prevent HIV in those who have been exposed to the virus.
“Early studies of the use of this medication as post-exposure prophylaxis therapy in other coronaviruses such as SARS and MERS have been promising,” says Dr. Darrell Tan, the study’s lead investigator who is also a scientist at the MAP Centre for Urban Health Solutions and an infectious disease physician at St. Michael’s. “These are so-called ‘cousin’ viruses to COVID-19 and we want to understand whether lopinavir/ritonavir as PEP could impact its spread as well.”